1. Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia 
S. Imbert, L. Castain, A. Pons, S. Jacob, I. Meyer, M. Palous, C. Vezinet, O. Langeron, C. Hennequin, A. Monsel, A. Fekkar 
Clinical Microbiology and Infection 
Volume 22, Issue 10, Pages 891.e5-891.e8 (October 2016)
DOI: /j.cmi
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2. Fig. 1
Timeline for solid organ transplant recipient who developed Candida glabrata candidaemia due to related isolates presenting different antifungal susceptibility patterns. Day 1 (D1) corresponds to day patient received graft. Circled MICs indicate determinations of minimal inhibitory concentrations by Etest and EUCAST (*) or by Etest only. EUCAST, European Committee on Antimicrobial Susceptibility Testing; MIC, minimum inhibitory concentration.
Clinical Microbiology and Infection  , 891.e5-891.e8DOI: ( /j.cmi )
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions